Atossa Therapeutics, Inc. (ATOS)
2.23
-0.14
(-5.91%)
USD |
NASDAQ |
Oct 29, 16:00
2.25
+0.02
(+0.90%)
After-Hours: 20:00
Atossa Therapeutics Price : 2.23 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 2.35 | 2.375 | 2.22 | 2.23 | 68008.00 |
| Oct 28, 2026 | 2.38 | 2.425 | 2.36 | 2.37 | 29463.00 |
| Oct 27, 2026 | 2.44 | 2.628 | 2.37 | 2.38 | 24835.00 |
| Oct 26, 2026 | 2.58 | 2.58 | 2.40 | 2.45 | 35078.00 |
| Oct 23, 2026 | 2.74 | 2.85 | 2.60 | 2.60 | 77025.00 |
| Oct 22, 2026 | 2.49 | 2.77 | 2.46 | 2.72 | 90656.00 |
| Oct 21, 2026 | 2.53 | 2.585 | 2.38 | 2.53 | 189632.0 |
| Oct 20, 2026 | 2.54 | 2.67 | 2.51 | 2.54 | 36755.00 |
| Oct 19, 2026 | 2.66 | 2.76 | 2.51 | 2.56 | 80522.00 |
| Oct 16, 2026 | 2.59 | 2.95 | 2.51 | 2.91 | 104625.0 |
| Oct 15, 2026 | 2.78 | 3.12 | 2.53 | 2.65 | 227028.0 |
| Oct 14, 2026 | 2.52 | 2.81 | 2.450 | 2.78 | 238706.0 |
| Oct 13, 2026 | 2.35 | 2.60 | 2.30 | 2.56 | 71415.00 |
| Oct 12, 2026 | 2.44 | 2.53 | 2.335 | 2.389 | 81419.00 |
| Oct 09, 2026 | 2.45 | 2.74 | 2.12 | 2.44 | 265612.0 |
| Oct 08, 2026 | 2.46 | 2.478 | 2.385 | 2.42 | 101012.0 |
| Oct 07, 2026 | 2.41 | 2.49 | 2.41 | 2.46 | 19070.00 |
| Oct 06, 2026 | 2.46 | 2.54 | 2.43 | 2.45 | 54625.00 |
| Oct 05, 2026 | 2.38 | 2.500 | 2.341 | 2.45 | 53315.00 |
| Oct 02, 2026 | 2.23 | 2.379 | 2.17 | 2.34 | 74272.00 |
| Oct 01, 2026 | 1.96 | 2.30 | 1.96 | 2.27 | 113600.0 |
| Sep 30, 2026 | 1.99 | 2.15 | 1.95 | 1.95 | 67768.00 |
| Sep 29, 2026 | 2.06 | 2.16 | 1.96 | 1.99 | 83319.00 |
| Sep 28, 2026 | 1.905 | 2.04 | 1.82 | 1.96 | 152933.0 |
| Sep 25, 2026 | 2.06 | 2.065 | 1.89 | 1.90 | 77844.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.76 |
| Alnylam Pharmaceuticals, Inc. | 174.00 |
| Anika Therapeutics, Inc. | 21.79 |
| Savara, Inc. | 4.95 |
| Vericel Corp. | 42.91 |
Price Related Metrics
| PEG Ratio | -0.0038 |
| Price to Book Value | 0.8294 |
| Earnings Yield | -194.8% |
| Market Cap | 22.25M |
| PEGY Ratio | -0.0038 |